SCARLETRED Holding

SCARLETRED Holding, founded in 2016 and based in Vienna, Austria, is a digital health innovator specializing in dermatology. The company's core offering is a medical-grade, regulatory-compliant platform that combines a mobile application for standardized image capture with cloud-based AI analytics for skin assessment. This technology is deployed primarily to support decentralized clinical trials for pharmaceutical and biotech companies, as well as for tele-dermatology services. SCARLETRED positions itself at the intersection of medical device software, data analytics, and patient-centric care delivery.

Proprietary mobile and cloud-based platform for standardized, calibrated skin image capture and AI-powered analysis. Includes a physical color calibration card (Scarletred®Vision Card) for consistent imaging across devices. The platform is a regulated Software as a Medical Device (SaMD).

SCARLETRED competes in the digital dermatology and clinical trial imaging space against large, integrated clinical trial technology providers (e.g., Medidata, IQVIA) and specialized startups offering digital endpoints or eClinical platforms. Its key differentiation is the patented hardware+software approach to standardized color calibration, which addresses a critical gap in remote skin assessment reliability. However, competitors may develop alternative technical solutions or compete on price and integration.